---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-015015"
form_type: "8-K"
ticker: "ABBV"
cik: "0001551152"
company_name: "AbbVie Inc."
filed_at: "2025-02-19T23:59:59+00:00"
generated_at: "2026-05-26T11:48:58.144021+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# AbbVie issues $4B in senior notes across four maturities to refinance near-term debt

## Summary
- Issued $1.25B 4.650% notes due 2028, $1B 4.875% due 2030, $1B 5.200% due 2035, $750M 5.600% due 2055.
- Net proceeds ~$3.98B after underwriting discounts and expenses.
- Proceeds plus cash on hand to repurchase or repay $3.75B 3.600% notes due May 2025 and/or $2.89B 3.800% notes due March 2025.
- Closing expected February 26, 2025; underwriters include BofA, J.P. Morgan, Morgan Stanley, Barclays, Mizuho.
- Offering also includes refinancing of $130M Allergan Funding 3.800% notes due March 2025 or general corporate purposes.

## SEC filing metadata
- accession: 0001104659-25-015015
- form_type: 8-K
- ticker: ABBV
- cik: 0001551152
- company_name: AbbVie Inc.
- filed_at: 2025-02-19T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551152/000110465925015015/0001104659-25-015015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551152/000110465925015015/tm255723d4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-015015
- JSON: https://secwatch.observer/filing/0001104659-25-015015.json
- Plain text: https://secwatch.observer/filing/0001104659-25-015015.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.